San
Francisco 12 April 2019 Anxiety Disorders And Depression Treatment Market Analysis By Product
(Antidepressant Drugs, SSRIs, SNRIs, Benzodiazepines, Devices And Therapy, TMS,
DBS, VBS), By Indication (MDD, OCD, Phobia), And Segment Forecasts, 2018 - 2025
The global anxiety disorders and depression treatment market is expected to reach a value of USD 18.3 billion by 2025.
The rising incidence of depression worldwide is anticipated to drive the market
growth in the coming years. Increasing adoption of devices and psychotherapies
has resulted in the declining demand for antidepressants in the recent years.
The rising geriatric population prone to
depression and surging prevalence of anxiety disorders, including phobias and
generalized anxiety disorder, are further contributing toward the growing
demand for antidepressants to treat mental illnesses over the forecast period.
Moreover, the introduction of technologically advanced therapies, such as
medical implants used for brain stimulation and virtual reality exposure
therapies using smartphone-based applications, furnish patients with innovative
treatment alternatives.
Access Research Report of Anxiety
Disorders & Depression Treatment Market @ http://www.grandviewresearch.com/industry-analysis/anxiety-disorders-and-depression-treatment-market
Further key findings from the study suggest:
· Presently, the antidepressant drugs segment
holds the largest revenue share. However, due to the rising occurrence of
adverse events associated with these therapeutics, this segment’s growth is
expected to wane
· Patent expiration of branded medicines and
introduction of generic biosimilars, which are cost effective, are responsible
for the shrinking market of antidepressants
· On the other hand, introduction of new
medicines, such as Duloxetine, Fetzima, and Brintellix, are predicted to fuel
the demand for therapeutics in the coming years
· Furthermore, the personalized therapies and
devices segment is expected to register the fastest growth owing to its growing
adoption by healthcare professionals as they exert fewer side effects as
compared to drugs
· Cognitive behavioral therapy held the
majority share in 2015 and is expected to register substantial growth in the
coming years owing to the shifting preference of healthcare professionals
toward this segment
· Transcranial Magnetic Stimulation (TMS) is
predicted to witness lucrative growth due to the introduction of
technologically advanced devices such as MagVita TMS Therapy System by
MagVenture in July 2015 and Brainsway Deep TMS in January 2013
· North American regional segment for anxiety
disorders and depression treatment reached a saturation level owing to the
availability of several medicines and the high prevalence of depressive
disorders in this region
· Pfizer, Inc.; Eli Lilly and
Company;GlaxoSmithKline plc; AstraZeneca; and H. Lundbeck A/S captured a
sizable share in 2015 and accounted for more than 60% of the antidepressant
drugs vertical
· The revenue captured by antidepressants is
expected to decrease with generics dominating the market during the forecast
period
Browse more reports of this category by Grand View
Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has
segmented the anxiety disorders and depression treatment market by product,
indication, and region:
Anxiety Disorder and Depression Treatment
Product Outlook (Revenue, USD Million, 2014 - 2025)
·
Antidepressant drugs
·
Therapy & Devices
Anxiety Disorder and Depression Treatment Indication Outlook
(Revenue, USD Million, 2014 - 2025)
·
MDD
·
OCD
·
Phobias
·
Others
Anxiety Disorder and Depression Treatment
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
The Middle East and Africa
Access Press Release of
Anxiety
Disorders & Depression Treatment Market@ https://www.grandviewresearch.com/press-release/global-anxiety-disorders-and-depression-treatment-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment